Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Anti-CMV activity of BDCRB evaluated in newly designed preclinical model

April 9, 1999

RPR-CMV-423: a promising candidate for treatment of human CMV infection

April 9, 1999

Versicor and Pharmacia & Upjohn join forces for development of new oxazolidinones

April 9, 1999

FDA decides to continue review of Relenza NDA

April 8, 1999

Production and activity of new antimicrobial compound described by Teijin

April 8, 1999

Novel antibiotic active against acid-fast bacteria presented at recent Japanese congress

April 7, 1999

New carbapenems synthesized at Merck useful against resistant staphylococci

April 7, 1999

International team identifies myristic acid analogues with antipicornaviral activity

March 31, 1999

In vitro and in vivo profile of SB-265805 discussed at European microbiology meeting

March 31, 1999

Emoxipin analogues studied by Russian team in animal models of infection

March 31, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...